Read More Apparatus World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy! Nov 29, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Dec 01, 2024
Read More Medical Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Nov 26, 2024
Read More Medical Cutting-edge 'peptide' shows promise in stopping breast cancer metastasis! Dec 02, 2024
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Nov 30, 2024
Read More Medical New Research Shows Promise For Bone Marrow Transplant Recipient Patients To Reduce Treatment Side Effects! Nov 19, 2024
